Method for preparation of a group 4 metal silicate and use thereof
US-10286390-B2 · May 14, 2019 · US
US11964266B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11964266-B2 |
| Application number | US-201916506377-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 9, 2019 |
| Priority date | Jul 9, 2019 |
| Publication date | Apr 23, 2024 |
| Grant date | Apr 23, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A process for removing Co 2+ , Pb 2+ , Cd 2+ and Cr 3+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with an ion exchange composition to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchange composition. The ion exchange compositions are represented by the following empirical formula: A m Zr a Ti b Sn c M d Si x O y . A composition comprising the above ion exchange compositions in combination with bodily fluids or dialysis solution is also disclosed. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.
Opening claim text (preview).
We claim as our invention: 1. A process for removing Co 2+ , Pb 2+ , Cd 2+ , Cr 2+ toxins or mixtures thereof from bodily fluids comprising contacting said bodily fluid containing the toxins with an ion exchanger to remove the toxins from the fluid by ion exchange between said ion exchanger and said bodily fluid, the ion exchanger selected from zirconium metallate, titanium metallate, tin metallate, multinary metallate containing more than one of zirconium, titanium and tin, and mixtures thereof, the metallates respectively having an empirical formula on an anhydrous basis of: A m Zr a Ti b Sn c M d Si x O y where A is an exchangeable cation comprising potassium ion, sodium ion, rubidium ion, cesium ion, calcium ion, magnesium ion, hydronium ion or mixtures thereof, M is at least one framework metal selected from the group consisting of hafnium (4+) or niobium (5+), “m” is a mole ratio of A to total metal (total metal=Zr+Ti+Sn+M) and has a value from 0.10 to 15, “a” is a mole fraction of total metal that is Zr and has a value from zero to 1, “b” is a mole fraction of total metal that is Ti and has a value from zero to 1, “c” is a mole fraction of total metal that is Sn and has a value from zero to 1, where a+b+c >0, “d” is a mole fraction of total metal that is M and has a value from zero to less than 1, where a+b+c+d=1 and, “x” is a mole ratio of Si to total metal and has a value from 0 to 12, and “y” is a mole ratio of O to total metal and has a value from 2.1 to 33. 2. The process of claim 1 wherein the bodily fluid is selected from the group consisting of whole blood, blood plasma, or other component of blood, gastrointestinal fluids and dialysate solution containing blood, blood plasma, other component of blood or gastrointestinal fluids. 3. The process of claim 1 where M is hafnium (+4) or niobium. 4. The process of claim 1 where x=0. 5. The process of claim 1 where a +c+d=0. 6. The process of claim 1 where A is a mixture of calcium and sodium. 7. The process of claim 1 wherein the ion exchanger is packed into hollow fibers incorporated into a membrane. 8. The process of claim 1 wherein said ion exchanger is contained on particles coated with a coating comprising a cellulose derivative composition. 9. The process of claim 1 wherein said process is a hemoperfusion process wherein said bodily fluid is passed through a column containing said ion exchanger. 10. The process of claim 1 wherein a dialysate solution is introduced into a peritoneal cavity and then is flowed through at least one adsorbent bed containing at least one of said ion exchanger. 11. The process of claim 1 wherein said ion exchanger is formed into a shaped article to be ingested orally, followed by ion exchange between said ion exchanger and said Co 2+ , Pb 2+ , Cd 2+ , Cr 2+ toxins contained in a gastrointestinal fluid in a mammal's intestines and then by excretion of said ion exchanger containing said toxins. 12. The process of claim 11 wherein said shaped article is coated with a coating that is not dissolved by conditions within a stomach.
Processes using inorganic exchangers · CPC title
with dialysate regeneration · CPC title
Dialysates therefor · CPC title
Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents · CPC title
by absorption (A61M1/3675 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.